Deutsche Bank Ag\ Sensei Biotherapeutics, Inc. Transaction History

Deutsche Bank Ag\

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$1.49 - $2.3 $16,901 - $26,088	-11,343 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$2.22 - $6.07 $2,974 - $8,133	-1,340 Reduced 10.57%	11,343 $26,000
Q4 2021 Feb 11, 2022	BUY	$4.85 - $10.48 $3,210 - $6,937	662 Added 5.51%	12,683 $74,000
Q3 2021 Nov 04, 2021	BUY	$6.89 - $11.99 $50,765 - $88,342	7,368 Added 158.35%	12,021 $126,000
Q2 2021 Aug 11, 2021	SELL	$9.1 - $15.14 $116,288 - $193,474	-12,779 Reduced 73.31%	4,653 $45,000
Q1 2021 May 13, 2021	BUY	$12.04 - $22.75 $209,881 - $396,578	17,432 New	17,432 $253,000

2.23M

Ticker SNSE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,720,300
Market Cap $16M
Description
Sensei Biotherapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of immunotherapies with an initial focus on treatments for cancer. It develops proprietary ImmunoPhage platform, an immunotherapy approach that is designed to utilize bacteriophage to induce a focused and coordinated innate and adaptive immune res...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.